{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: CONCLUSIONS : Our results indicate that trazodone at 2 . 5 - 20 mg / kg does not block pre - and postsynaptic striatal D2 DA receptors , while at 30 , 40 and 50 mg / kg it blocks postsynaptic striatal D2 DA receptors .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| D2 DA receptors |\n\nExplanation:\n\nIn the given paragraph, the term \"D2 DA receptors\" is mentioned as being blocked by trazodone at certain dosages. D2 DA receptors, or dopamine D2 receptors, are not exactly a \"disease\" entity, but they are involved in various neurological and psychiatric conditions, such as Parkinson's disease and schizophrenia. However, to adhere strictly to the request for \"Disease\" entities, I have listed \"D2 DA receptors\" as the valid entity in the provided paragraph."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n\nExplanation:\n\nUpon closer examination, there are no clear \"Disease\" entities mentioned in the paragraph. The text discusses the effects of trazodone on D2 DA receptors, but it does not explicitly mention any specific diseases. Therefore, I cannot provide a table with any valid \"Disease\" entities based on the given paragraph."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: CONCLUSIONS : Our results indicate that trazodone at 2 . 5 - 20 mg / kg does not block pre - and postsynaptic striatal D2 DA receptors , while at 30 , 40 and 50 mg / kg it blocks postsynaptic striatal D2 DA receptors .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| trazodone |\n| pre- and postsynaptic striatal D2 DA receptors |\n\nIn the given paragraph, the two chemical entities are:\n\n1. trazodone\n2. pre- and postsynaptic striatal D2 DA receptors"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| trazodone |\n\nIn the paragraph, the term \"pre- and postsynaptic striatal D2 DA receptors\" is not a chemical entity, but rather a type of receptor that the chemical compound trazodone interacts with. Therefore, the only clear chemical entity in the paragraph is:\n\n1. trazodone"}
  ]
}